9700_w08_qp_4
A paper of Biology, 9700
Questions:
11
Year:
2008
Paper:
4
Variant:
0

Login to start this paper & get access to powerful tools

1
2
For Examiner’s Use shows the CFTR (cystic fibrosis transmembrane conductance regulator) protein in a plasma (cell surface) membrane. Describe the normal function of the CFTR protein. On , use the letter E to indicate the external face of the membrane. State how you identified this face. Cystic fibrosis is caused by a recessive allele of the CFTR gene. Explain the meaning of the term recessive allele. For Examiner’s Use Explain how cystic fibrosis affects the function of the lungs. As cystic fibrosis is caused by a recessive allele of a single gene, it is a good candidate for gene therapy. Trials were undertaken in the 1990s, attempting to deliver the normal allele of the CFTR gene into cells of the respiratory tract, using viruses or liposomes as vectors. Explain how viruses deliver the allele into cells. For Examiner’s Use In some people with cystic fibrosis, the allele has a single-base mutation which produces a ‘nonsense’ codon within the gene. Explain how this mutation would prevent normal CFTR protein being produced. A new type of drug, PTC124, enables translation to continue through the nonsense codon. Trials in mice homozygous for a CFTR allele containing the nonsense codon have found that animals treated with PTC124 produce normal CFTR protein in their cells. The drug is taken orally, and is readily taken up into cells all over the body. Using your knowledge of the progress towards successful gene therapy for cystic fibrosis, suggest why PTC124 could be a simpler and more reliable treatment for this disease.
3
4
For Examiner’s Use Outline the hybridoma method for the production of a monoclonal antibody. Herceptin is a monoclonal antibody used in the treatment of some breast cancers. It binds strongly to molecules of a receptor protein, HER2, that is produced in abnormally large quantities in the plasma (cell surface) membranes of about 30% of human breast cancers. Investigations have been made into the most effective way to use Herceptin to treat breast cancer. One experiment investigated the ability of different treatments to induce cell death in breast cancer cells. Herceptin and X-ray treatment were used both separately and together. The results are shown in . 1.0 2.0 ability to induce cell death / arbitrary units no treatment Herceptin only X-ray treatment only Herceptin and X-ray treatment For Examiner’s Use With reference to , compare the effects on breast cancer cells of the different treatments calculate the percentage increase in the ability to induce cell death of using Herceptin and X-ray treatment compared with using Herceptin only. Show your working. For Examiner’s Use A second experiment investigated the effect of increasing doses of X-rays on the survival of breast cancer cells in the presence and absence of Herceptin. The results are shown in . 1.0 10.0 mean percentage of cells surviving (log scale) absorbed dose of X-rays / J kg–1 X-rays and Herceptin X-rays With reference to , compare the effects of increasing doses of X-rays on cells in the presence and absence of Herceptin suggest an explanation for the effect of Herceptin.
5
6
7
8
9